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Abstract
Background: Endocytosis controls localization-specific signal transduction via epidermal growth factor receptor (EGFR), as
well as downregulation of that receptor. Extracellular matrix (ECM)-integrin coupling induces formation of macromolecular
complexes that include EGFR, integrin, Src kinase and p130Cas, resulting in EGFR activation. In addition, cell adhesion to
ECM increases EGFR localization at the cell surface and reduces EGFR internalization. The molecular mechanisms involved
are not yet well understood.
Methodology/Principal Findings: We investigated the molecular mechanism by which p130Cas affects the endocytic
regulation of EGFR. Biochemical quantification revealed that cell adhesion to fibronectin (FN) increases total EGFR levels and
its phosphorylation, and that p130Cas is required for this process. Measurements of Texas Red-labeled EGF uptake and cell
surface EGFR revealed that p130Cas overexpression reduces EGF-induced EGFR internalization, while p130Cas depletion
enhances it. In addition, both FN-mediated cell adhesion and p130Cas overexpression reduce EGF-stimulated dynamin
phosphorylation, which is necessary for EGF-induced EGFR internalization. Coimmunoprecipitation and GST pull-down
assays confirmed the interaction between p130Cas and dynamin. Moreover, a SH3-domain-deleted form of p130Cas, which
shows diminished binding to dynamin, inhibits dynamin phosphorylation and EGF uptake less effectively than wild-type
p130Cas.
Conclusions/Significance: Our results show that p130Cas plays an inhibitory role in EGFR internalization via its interaction
with dynamin. Given that the EGFR internalization process determines signaling density and specificity in the EGFR pathway,
these findings suggest that the interaction between p130Cas and dynamin may regulate EGFR trafficking and signaling in
the same manner as other endocytic regulatory proteins related to EGFR endocytosis.
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Introduction
Signaling via the ubiquitously expressed epidermal growth
factor receptor (EGFR) is involved in the regulation of cell
motility, proliferation, survival and differentiation [1–3]. Ligand-
dependent asymmetric dimerization of EGFR results in activation
of EGFR tyrosine kinase and trans-autophosphorylation [4,5]. The
autophosphorylation sites in the activated EGFR then act as
nucleation sites for the formation of specific receptor-signaling
protein complexes and downstream kinase (e.g., Erk, Akt) cascades
that initiate cell context-specific signaling pathways [6,7].
EGF ligand induces the translocation of activated EGFRs to
clathrin-coated pits and their rapid internalization into early
endosomes. Endosomal sorting of EGFRs is followed by lysosomal
targeting and receptor degradation. EGFR internalization is
therefore thought to be a major pathway via which the receptor
is downregulated. Alternatively, endosome-associated EGFRs may
continue to interact with compartment-specific signaling proteins.
Thus the endocytic trafficking of EGFR determines the duration,
intensity and specificity of its signal transduction [8–13]. In short,
endocytosis likely plays multiple roles in the regulation of signaling
via EGFRs.
A large number of regulatory proteins are involved in EGFR
internalization and signaling [1,12,14]. Dynamin GTPase, one of
the critical regulators of endocytic EGFR internalization, catalyzes
membrane fission and vesicle budding [15]. Dynamin K44A
(Lys44RAla) mutation, which reduces dynamin GTPase activity,
inhibits EGFR internalization and, in turn, increases total EGFR
levels. In addition, the K44A dynamin mutant reduces specific
tyrosine phosphorylation of EGFR and alters downstream
signaling, including signaling by Erk [16,17]. Knocking down
key protein components of clathrin-mediated endocytosis, such as
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addition, hSef binding to EGFR and Vav2, which interact with
Gapvd1, modulates EGFR internalization and trafficking, and also
affects EGF signaling [10,18].
Integrin also regulates EGFR internalization and signaling [19–
21]. Cell adhesion to fibronectin (FN) induces slight increase of
EGFR [21] and formation of macromolecular complexes
comprised of EGFR, integrin, p130Cas and Src kinase. Upon
complex formation, specific EGFR tyrosine residues, including
Tyr 845, are phosphorylated, thereby activating EGFR signaling
[20,21]. In contrast to the internalization of activated EGFRs
induced by EGF binding, cell adhesion-induced EGFR activation
increases localization of EGFRs at the cell surface [20]. The
mechanism by which integrin-EGFR crosstalk attenuates EGFR
internalization is not well understood, however.
P130Cas is an adaptor protein participating in cell adhesion,
motility and transformation [22,23]. P130Cas has multiple
protein-protein interaction domains, including a SH3-domain, a
large tyrosine kinase substrate binding domain (SD), and a Src-
binding domain (SBD) [22,24–26]. The SDs are characterized by
fifteen tyrosine-Xaa-Xaa-proline (YXXP) motifs that are regarded
as major sites of adhesion-dependent phosphorylation [24,25].
The finding that knocking out p130Cas diminishes adhesion-
induced EGFR phosphorylation indicates that p130Cas is a
functional mediator of integrin-EGFR crosstalk [20]. Moreover,
overexpression p130Cas is, by itself, sufficient to induce ligand-
independent EGFR phosphorylation of Tyr 845 [27]. However,
the mechanism by which p130Cas contributes to the EGFR
signaling pathway remains unclear.
The objective of the present study was to investigate the role of
p130Cas in the EGFR internalization pathway. Here we show that
p130Cas promotes EGFR activation and increases total EGFR
levels under conditions of FN-mediated cell adhesion. In addition,
p130Cas inhibits EGF-induced EGFR internalization and dyna-
min phosphorylation. We also demonstrate that the SH3-domain
of p130Cas interacts with the proline-rich domain (PRD) of
dynamin, and this interaction is essential for p130Cas-mediated
inhibition of dynamin phosphorylation and EGFR internalization.
Results
P130Cas enhances EGFR activation in response to cell
adhesion
It is well known that p130Cas is required for cell adhesion-
induced EGFR phosphorylation [20], but it was not known
whether p130Cas also contributes to cell adhesion-induced
increases in EGFR localization at the cell surface. To assess the
role of p130Cas in EGFR activation and stabilization at the cell
surface induced by cell adhesion, we transfected A431 cells with
non-targeting or p130Cas-specific siRNA and examined the effect
of knocking down p130Cas. After incubating the transfectants for
60 h, the cells were suspended for 1 h and then plated on FN-
coated dishes. Depletion of p130Cas from A431 cells significantly
reduced both total EGFR tyrosine phosphorylation (Figure 1A, p-
Tyr blot) and EGFR phosphorylation at Tyr 845 (Figure 1A,
pEGFR blot). Interestingly, adhesion of control cells to FN elicited
a slight increase in total EGFR levels, but adhesion of p130Cas-
depleted cells did not.
Given that EGF ligand induces rapid internalization and
degradation of EGFRs, we analyzed the effect of p130Cas
depletion in the presence of EGF. A431 cells were placed in
suspension, and then plated on FN-coated or uncoated culture
dishes and treated with 100 ng/ml EGF for 2 h. In control cells,
FN-mediated cell adhesion increased total EGFR levels and
attenuated EGF-induced EGFR degradation. In p130Cas-deplet-
ed cells, by contrast, cell adhesion to FN had no effect on total
EGFR levels, and the attenuation of EGFR degradation was
abolished (Figure 1B). This suggests that p130Cas plays a
regulatory role in EGFR internalization and/or the stable
localization of EGFR at the cell surface.
P130Cas negatively regulates internalization and
degradation of EGFR
To further examine the role of p130Cas in EGFR internaliza-
tion, we tested the effect of p130Cas on EGF-induced EGFR
internalization and subsequent degradation. After biotinylation of
cell surface proteins, we traced the effect of EGF on cell surface
levels of EGFR. As shown in figure 2A, treating A431 cells with
EGF time-dependently reduced levels of EGFR at the cell surface,
which is consistent with earlier reports [28]. Interestingly,
knocking down p130Cas significantly accelerated the elimination
of biotinylated EGFR from the cell surface, implying rapid
induction of EGFR internalization. The degradation rate of total
EGFR was also increased by p130Cas depletion.
We next used Texas Red-conjugated EGF to visually track the
EGFR. P130Cas-depleted A431 cells exhibited about 35% greater
uptake of Texas Red-EGF than control cells (Figure 2B), while
overexpression of exogenous p130Cas dramatically reduced EGF
uptake. Cos7 cells overexpressing GFP-Cas exhibited less uptake
of Texas Red-EGF than their untransfected neighbor cells and
cells transfected with empty GFP vector (Figure 3A). We also
assessed the effect of overexpressing GFP-p130Cas in HeLa cells
Figure 1. P130Cas enhances EGFR activation and stabilization
at the cells surface in response to cell adhesion. (A) A431 cells
were transfected with non-targeting (siRNA ct) or p130Cas-specific
siRNA (siRNA Cas) duplexes and cultured for 60 h. The cells were then
serum starved for 12 h, incubated in suspension (Sus) for 1 h, and
plated on FN for 0 min, 30 min or 3 h. Tyrosine phosphorylation of
EGFR was analyzed by immunoblotting EGFR immunoprecipitates with
an anti-phosphotyrosine antibody (pTyr). Right panel: Graphs showing
quantification of EGFR phospho-Tyr levels normalized to total EGFR
(top) and total EGFR levels normalized to tubulin (bottom). (B) A431
cells were transfected as described above and then serum starved for
12 h, incubated in suspension (Sus) for 1 h and plated on uncoated or
FN-coated dishes for 30 min. The cells were then left untreated or
treated with EGF (100 ng/ml) for 2 h. Right panel: Graph showing
quantification of total EGFR levels normalized to tubulin.
doi:10.1371/journal.pone.0020125.g001
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less uptake of Texas Red-EGF into HeLa cells overexpressing
GFP-p130Cas than into untransfected control cells, but there was
no significant difference between transfected or untransfected cells
120 min after EGF treatment (Figure 3B). Taken together, these
findings indicate that p130Cas expression negatively regulates
EGF-induced EGFR internalization.
FN-mediated cell adhesion or p130Cas overexpression
reduces EGF-dependent dynamin phosphorylation
Upon EGF binding to EGFR, dynamin GTPase is activated,
which promotes the receptor’s internalization [29]. To determine
the regulatory mechanism by which p130Cas inhibits EGFR
internalization and degradation, we tested whether cell adhesion or
p130Cas could alter EGF-induced dynamin phospho-activation.
Cos7 cells overexpressing GFP- dynamin I were plated on PDL- or
FN-coated dishes, with or without EGF treatment. Subsequent
immunoprecipitation revealed that EGF treatment leads to
phosphorylation of GFP-dynamin I and that the phosphorylation
level is higher in cells plated on PDL than on FN, suggesting cell
adhesion can alter EGF-induced dynamin phosphorylation
(Figure 4A). To addressthepossibility that p130Casaffectsdynamin
phosphorylation, we tested the effect of p130Cas overexpression on
EGF-induced dynamin I phosphorylation. As shown in figure 4B,
levels of GFP-dynamin I phosphorylation were lower in cells
overexpressing Myc-tagged p130Cas (Myc-Cas) than in untrans-
fected cells or cells transfected with empty vector.
Because p130Cas is thought to be important transducer of
integrin receptor signaling [22], we tested whether FN adhesion
and Myc-Cas overexpression exert a synergistic effect on dynamin
I phosphorylation. For this analysis, Cos7 cells were transfected
with plasmids, as indicated, and then plated on FN, with or
Figure 2. Depletion of p130Cas enhances EGFR internalization
and EGF uptake. (A) A431 cells were transfected with non-targeting
or p130Cas-specific siRNA, cultured for 60 h and then serum starved for
12 h. After treatment with 100 ng/ml EGF for 10 min, 1 h, or 3 h, cell
surface proteins were biotinylated and analyzed as described in the
Materials and Methods. Right panel: Graph showing quantification of
the remaining surface EGFR (top) or total EGFR (bottom) levels after EGF
treatment. Data are from 3 independent experiments. (B) A431 cells
transfected with non-targeting or p130Cas-specific siRNA were incubate
with Texas Red-EGF on ice for 60 min. After washing with ice-cold
DMEM, the cells were incubated at 37uC for 15 min to allow
internalization. Samples were then visualized by immunofluorescence
microscopy, and the images were captured digitally. Representative
images are shown; the arrows indicate the stronger Texas Red-EGF
signals seen in p130Cas-depeleted cells. Scale bar, 20 mm. Right panel:
Box and whisker plots of Texas Red-EGF (TxRed-EGF) intensity. Fifteen
images from each group were selected, and the TxRed-EGF intensity in
the cell area was analyzed using MetaMorph software. The data are
expressed in arbitrary units (A.U). The middle line in each box indicates
the median, the top of each box indicates the 75th percentile, the
bottom indicates the 25th percentile, the dotted line indicates average,
and the whiskers indicate the extent of the 10th and 90th percentiles,
respectively. *P,0.05 (Student’s t-test).
doi:10.1371/journal.pone.0020125.g002
Figure 3. P130Cas overexpression negatively regulates EGF
uptake. (A) Left panels: Representative Cos7 cells transfected with
empty vector (GFP-EV) or GFP-p130Cas (GFP-Cas) were treated with
Texas Red-EGF as described in above. The black lines indicate the
transfected cell areas. Scale bars, 20 mm. Right panel: Box and whisker
plots of the Texas Red-EGF (TxRed-EGF) intensity per cell. Approxi-
mately 40 transfected cells and 50 untransfected neighbour cells were
used, and the data are expressed in arbitrary units (A.U). *P.0.3, n.s; not
significant, **P,0.05. (B) HeLa cells transfected with empty vector (GFP-
EV) or GFP-p130Cas (GFP-Cas) were treated with Texas Red-EGF for the
indicated times. Top panels: Representative images; black lines indicate
the transfected cell areas. Scale bar, 20 mm. Lower panel: Box and
whisker plots of the Texas Red-EGF (TxRed-EGF) intensity per cell. At
least 20 transfected cells and .50 untransfected neighbor cells from 15
independent images were analyzed at each time point, and the data are
expressed in arbitrary units (A.U). *P.0.5, **P,0.001, ***P,0.01,
****P.0.2.
doi:10.1371/journal.pone.0020125.g003
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pression and FN-mediated adhesion dramatically inhibited
dynamin I phosphorylation, suggesting integrin-mediated adhe-
sion and p130Cas may act in concert to regulate dynamin I
phosphorylation (Figure 4C). To further confirm the role of
p130Cas in the regulation of dynamin phosphorylation, we treated
p130Cas-depleted A431 cells with EGF and found that tyrosine
phosphorylation of endogenous dynamin II was approximately 2-
fold increased by EGF treatment in the p130Cas-depleted cells but
1.1-fold in the control cells (p130Cas wild type) (Figure 4D). These
results suggest that p130Cas is able to inhibit EGF-induced
phospho-activation of dynamin.
The p130Cas SH3-domain interacts with the dynamin
Pro-rich domain (PRD)
The existence of p130Cas/dynamin complexes in mammalian
tissues was previously demonstrated through coimmunoprecipita-
tion of lysates from the seminiferous tubules and germ cells of adult
rats [30]. Bearing that in mind, inhibition of the EGF-induced
dynamin phosphorylation by p130Cas prompted us to investigate
whether p130Cas interacts with dynamin. Cos7 cells were
transiently transfected with GFP-dynamin, with or without a
plasmid encoding Myc-Cas. After coimmunoprecipitation, the
immunocomplexes were probed for GFP. The result showed that
GFP-dynamin I associates with Myc-Cas (Figure 5A) and with
endogenous p130Cas (Figure 5B). We then performed coimmu-
noprecipitation analyses using p130Cas deletion mutants lacking
the SH3-domain (Cas DSH3) or SD (Cas DSD) to identify the
p130Cas domain that interacts with dynamin. We found that
dynamin primarily bound to the SH3-domain of p130Cas via its
PRD (Figure 5C and D). To confirm the direct interaction
between p130Cas and dynamin, GST pull-down assays were
performed using purified GST-dynamin I PRD and cell lysates
from Cos7 cells overexpressing Myc-Cas. As shown in figure 5D,
GST-dynamin I PRD was pulled down with Myc-Cas, confirming
a specific interaction between p130Cas and the dynamin I PRD.
To further confirm p130Cas-dynamin interaction, we tested
whether p130Cas colocalizes with dynamin. After EGF treatment,
transiently expressed GFP-Cas and mRFP-dynamin I were readily
colocalized near cell edge (Figure 5E, arrows). Similar pattern of
co-localization was previously demonstrated by cortactin, a well-
characterized binding partner of dynamin [31]. It thus appears
that p130Cas can associate with dynamin, and that the p130Cas
SH3-domain mediates binding to the dynamin PRD.
Deletion of the p130Cas SH3-domain restores EGF-
induced dynamin phosphorylation and EGF
internalization
Given that p130Cas negatively regulates EGF-induced dynamin
phosphorylation and EGFR internalization (Figures 2, 3, 4), we set
out to determine the function of the p130Cas-dynamin interaction
during dynamin phosphorylation and EGFR internalization. Cos7
cells were cotransfected with GFP-dynamin I and wild-type
p130Cas or Cas DSH3, after which GFP-dynamin I was
immunoprecipitated in the presence or absence of EGF, and the
precipitate was immunoblotted with anti-phospho-tyrosine anti-
body (pTyr). Introduction of wild-type p130Cas into cells reduced
EGF-induced dynamin phosphorylation, and overexpression of
Cas DSH3 restored EGF-induced dynamin phosphorylation to
control levels (Figure 6A). Because dynamin phosphorylation
directly affected EGFR internalization, we investigated the effect
of Cas DSH3 on EGF uptake and found that EGF uptake was
significantly inhibited by overexpression of p130Cas (Figures 2 and
3). As expected, the inhibition was abolished in the cells expressing
Cas DSH3, which is unable to interact with the dynamin PRD
(Figure 6B). This suggests that the p130Cas-dynamin interaction is
required for the inhibitory effect of p130Cas on EGF-triggered
dynamin activation and subsequent EGFR internalization.
Discussion
P130Cas is a well-characterized adaptor/scaffold protein that
plays a key role in mediating integrin signaling and regulating
extracellular matrix (ECM)-dependent cell migration and cell
transformation [22–24]. There have been several reports that
p130Cas is important for formation of integrin-EGFR complexes,
and for modulation of EGF signaling in response to ECM stimuli
[20,22]. In the present study, we demonstrated that p130Cas is
also required for FN-dependent EGFR phosphorylation, without
stimulation by EGF, and for increases in total EGFR levels
stimulated by FN-mediated cell adhesion. In addition, p130Cas
tends to stabilize EGFR at the cell surface, even in the presence of
EGF. Overexpression of p130Cas in Cos7 and HeLa cells delayed
EGFR internalization, as indicated by EGF uptake assays.
Conversely, knocking down p130Cas using siRNA in A431 cells
Figure 4. FN-mediated cell adhesion or p130Cas overexpres-
sion reduces EGF-dependent dynamin phosphorylation. (A)
Cos7 cells were transfected with empty vector (GFP-EV) or GFP-dynamin
I and then incubated in suspension (Sus) for 1 h and plated on poly-D-
lysine (PDL) or fibronectin (FN) for 30 min, with or without 100 ng/ml
EGF. GFP-dynamin I immune complexes were generated from the lysate
and immunoblotted with antibodies specific to pTyr and GFP (top two
blots). In all our experiments, whole cell lysate was also imunoblotted as
indicated. A tubulin blot was used as loading control. The dotted box
highlights the EGF-induced dynamin phosphorylation. (B) Cos7 cells
were transfected with the indicated plasmids and then, after 24 h, were
incubated with or without 100 ng/ml EGF. Their lysates were
immunoprecipitated with anti-GFP antibody and immunoblotted with
anti-pTyr antibody. (C) Cos7 cells were transfected with indicated
plasmid set. After 24 h, immunoprecipitation and immunoblotting were
carried out as described in (B). (D) A431 cells were transfected with the
indicated siRNA and incubated for 60 h. Dynamin II immunocomplexes
were precipitated from the lysates and immunoblotted with anti pTyr
and anti-dynamin II antibodies. The relative levels of tyrosine
phosphorylated dynamin were quantified and normalized with
dynamin II level using ImageJ software. The results are depicted in
lower panel. WT, wild type; KD, knockdown.
doi:10.1371/journal.pone.0020125.g004
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which p130Cas negatively regulates EGFR internalization and
degradation, we assessed the relation between the activities of
p130Cas and dynamin GTPase. We found that p130Cas acting in
association with dynamin is able to downregulate EGF-induced
dynamin phosphorylation and, in turn, reduce dynamin activity.
The novel role of p130Cas in regulating EGFR endocytosis and
dynamin activity provides new mechanistic insight into cell
adhesion-dependent regulation of EGF signaling.
It was previously shown that ligand activated EGFRs are rapidly
internalized and, through endosomal trafficking, are targeted to
lysosomal degradation [2,11,32]. By contrast, EGFR activation
through integrin-mediated cell adhesion tends to reduce EGFR
internalization and to increase EGFR levels at the cell surface.
Moreover, it was previously reported that p130Cas plays an
essential role in cell adhesion-induced EGFR activation [20]. We
therefore hypothesized that, like FN-mediated adhesion, p130Cas
may contribute to EGFR stabilization at the cell surface.
Consistent with that notion, knocking down p130Cas attenuated
cell adhesion-mediated EGFR activation as well as adhesion-
induced increases in total EGFR levels without influencing EGFR
expression (Figure 1B and data not shown). Furthermore,
knockdown of p130Cas enhanced EGF-induced EGFR internal-
ization and degradation, while overexpression of p130Cas
inhibited EGF uptake, indicating that EGFR internalization is
likely regulated by p130Cas (Figure 2 and 3). Given that Neu (also
known as ErbB2, Her2) associates with the cell surface EGFR at
an early time point after EGF treatment [8], it is interesting to note
that depletion of p130Cas in A431 cells dramatically reduced
EGFR/Neu dimerization by EGF (Figure S1A).
Previous studies established that proteins regulating EGFR
endocytosis can also affect downstream signaling by EGF [14]. For
example, hSef overexpression attenuates EGFR degradation and
promotes activity in the EGF-triggered Erk pathway [10].
Exogenous Vav2 expression also delays EGFR internalization
and stabilizes EGFR at the cell surface, leading to enhanced
phosphorylation of EGFR, Erk and Akt [18]. In accordance with
previous reports, overexpression of p130Cas in Cos7 cells clearly
led to phosphorylation of EGFR and Akt (Figure S1B and C),
indicating that p130Cas is able to modulate downstream signaling
of EGF as well. However, phosphorylation of Erk, a downstream
mediator of EGFR signaling, was unaffected by changes in the
Figure 5. The SH3-domain of p130Cas interacts with the PRD of dynamin. (A) Cos7 cells were transfected with the indicated plasmids,
incubated for 24 h, and then lysed for immunoprecipitation with anti-GFP antibody. Immunocomplexes were immunoblotted with anti-Myc
antibodies. (B) Cos7 cells were transfected with empty vector (GFP-EV) or GFP-dynamin I and the incubated with or without 100 ng/ml EGF for the
indicated times. Cell lysates were immunoprecipitated with anti-Cas antibody (Cas2) and immunoblotted with anti-GFP antibody. Whole cell lysate
was also imunoblotted with the indicated antibodies. (C) Schematic representation of p130Cas deletion mutants and the results of interacting
domain mapping: WT, wild-type; DSH3, deletion of SH3-domain; DSD, deletion of deletion of the substrate domain; ‘2’ indicates a lack of detectable
interaction; ‘+’ indicates interaction. Lower panels: coimmunoprecipitation of a p130Cas deletion mutant and dynamin I. Cos7 cells were transfected
with the indicated constructs, and after 24 h the cell lysates were subjected to coimmunoprecipitation analysis with the indicated antibodies. (D) GST
pull-down assay verifying the interaction between p130Cas and dynamin. Myc-Cas was pulled down from the lysates of Cos7 transfectants by a GST-
dynamin PRD fusion protein immobilized on glutathione beads. The bound proteins were eluted, subjected to SDS-PAGE and immunoblotted using
anti-Myc antibody. (E) Cos7 cells were transfected with GFP-p130Cas (GFP-Cas) and mRFP-dynamin I. After 24 h, the cells were prepared for
immunofluorescence analysis as described in the Materials and Methods. The boxed areas are enlarged in the insets.
doi:10.1371/journal.pone.0020125.g005
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the complexity and/or the diversity of the Erk activation pathway
in different cell types and signaling contexts. [19,33].
EGFR internalization is regulated by several mechanisms, including
specific ligand binding, EGFR ubiquitination, the binding of the
endocytic machinery to EGFR and the participation of other accessory
proteins [11,12,28,32,34]. Src is well established as an endocytosis
regulator required for efficient receptor internalization [35]. EGF
treatment increasesSrc-dependent phosphorylation of dynamin,which
leads to EGFR internalization and degradation [29]. On the other
hand, it is noteworthy that both FN-mediated cell adhesion and the
Src-binding domain of p130Cas are able to transiently activate Src
kinase [36–38], nevertheless ectopic expression of p130Cas together
with FN-mediated cell adhesion reduced EGF-induced phosphoryla-
tion of dynamin (Figure 4). Thus the mechanism by which integrin-
EGFR crosstalk and p130Cas attenuates EGFR internalization may
involve differential regulation of Src kinase activity.
Given that the dynamin PRD is a potential target for numerous
proteins containing an SH3-domain [15], it seems plausible that
p130Cas reduces dynamin phosphorylation by binding to dynamin,
thereby interrupting the dynamin-Src association needed for the
reaction. This idea is supported by the observation that a p130Cas
mutantlackingtheSH3-domain (Cas DSH3)could not interact with
dynamin, nor could it inhibit EGF uptake (Figure 5 and 6).
However, it remains to be determined whether p130Cas-mediated
inhibition is achieved through interference with the Src-dynamin
interaction, or whether p130Cas activity leads to a reduction in
dynamin GTPase activity and self-assembly.
Src-dependent phospho-activation of dynamin is a crucial step for
several receptor proteins such as b2-adrenergic receptor, transferrin
receptor as well as EGFR. [29,39,40]. It is therefore possible that
p130Cas affects the internalization of other receptors in addition to
EGFR. Indeed, we observed that depletion of p130Cas from HeLa
cells increased Texas Red-transferrin uptake (Figure 6C). It would be
interesting to know whether p1 3 0 C a si sac o m m o nr e g u l a t o ro f
internalization of a wide spectrum of receptors through its inhibition
of receptor-mediated elevation in dynamin activity.
In summary, this work outlines the inhibitory role of p130Cas in
EGFR internalization and EGF-stimulated dynamin activation,
and provides evidence that p130Cas stabilizes EGFR at the cell
surface, thereby regulating its downstream signaling.
Materials and Methods
Ethics Statement
All animal experiments were approved by the Gwangju Institute
of Science and Technology Animal Care and Use Committee (the
permit number: GIST-2008-35).
Figure 6. Deletion of the p130Cas-SH3 domain restores EGF-induced dynamin phosphorylation and EGF internalization. (A) Cos7
cells transfected with the indicated plasmids were incubated with or without 100 ng/ml EGF, after which their lysates were immunoprecipitated with
anti-GFP antibody and immunoblotted with anti-pTyr and anti-GFP antibodies. Whole cell lysate was also imunoblotted with the indicated
antibodies. DSH3, deletion of SH3-domain, Lower panel: Graph showing levels of tyrosine phosphorylation of GFP-dynamin I normalized to tubulin.
(B) Cos7 cells were transfected with empty vector (Myc-EV), wild-type Myc-p130Cas (Myc-Cas), Myc-p130Cas SH3-domain deletion mutant (Myc-Cas
DSH3) or Myc-p130Cas SD deletion mutant (Myc-Cas DSD) and then treated with Texas Red-EGF as described as above. Upper panels: Representative
images; black lines indicates the transfected cell areas. Scale bars, 20 mm. Lower panel: Box and whisker plots of Texas Red-EGF (TxRed-EGF) intensity
per cell. For each condition, 37–120 transfected cells and 90–146 untransfected neighbor cells were assessed, and the data are expressed in arbitrary
units (A.U). *P.0.2, **P,0.001. (C) HeLa cells transfected with empty vector (GFP-EV) or GFP-p130Cas (GFP-Cas) were treated with Texas Red-
transferrin (TxRed-Tfn) as described above. Left panels: Representative images; black lines indicate the transfected cell areas. Scale bars, 10 mm. Right
panel: Box and whisker plots of Texas Red- transferrin intensity per cell. Approximately 20 transfected cells and 40 untransfected neighbor cells were
used, and the data are expressed in arbitrary units (A.U). *P.0.2, **P,0.005.
doi:10.1371/journal.pone.0020125.g006
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Rabbit anti-phospho-EGFR (Tyr 845), rabbit anti-phospho-Akt
(Ser473), mouse anti-phospho-Erk, rabbit anti-EGFR, goat anti-
dynamin II and rabbit anti-Neu antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Rabbit anti-phospho-
p130Cas (Tyr 165) was from Cell Signaling Technology (Beverly,
MA, USA). Mouse monoclonal anti-p130Cas (Clone 21) was from
BD Biosciences (San Jose, CA, USA). Mouse monoclonal anti-
phospho-Tyr (clone 4G10) and mouse monoclonal anti-dynamin I
(Hudy 1) were from Upstate Biotechnology (Lake Placid, NY,
USA). Mouse monoclonal anti-tubulin was from Sigma (St Louis,
MO, USA). Rabbit anti-GFP antibody was generated by
immunizing New Zealand White rabbits with the GST-GFP
protein and then purified. Mouse monoclonal anti-Myc (clone
9E10) antibody was generated from mouse ascites after hybridoma
injection. Rabbit anti-p130Cas (Cas2) was a gift from Dr. Hismaru
Hirai (University of Tokyo) [41]. Texas Red-conjugated EGF was
from Molecular Probes (Eugene, OR, USA), and Texas Red-
conjugated transferrin and recombinant EGF were from Invitro-
gen (Carlsbad, CA, USA). Human FN and synthetic poly-D-lysine
(PDL) were from Sigma (St Louis, MO, USA).
Cell culture and transfections
Cos7 and HeLa cells were obtained from the American Type
Culture Collection (ATCC, Manassas, USA), and A431 cells from
the Korean Cell Line Bank (KCLB, Seoul, Korea). Cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) (Hyclone). Cell
culture plates were coated with 20 mg/ml FN or 75 mg/ml PDL as
needed. Cover slips were coated with 0.2% gelatin before cell
plating.
pGEX4T1 dynamin I PRD, pEGFP dynamin I and pEGFP
dynamin II constructs were generously provided by Dr. Sunghoe
Chang (Seoul National University College of Medicine). mRFP-
dynamin I was a gift from Dr. Pietro DeCamilli (Yale University).
pEGFP p130Cas [42], Myc-tagged pcDNA3 wild-type and
mutant p130Cas plasmids were described earlier [43]. All
transfections were carried out using Lipofectamine (Invitrogen,
Carlsbad, CA, USA) or GeneExpresso 8000 (InnoVita, Gaithers-
burg, MD, USA) according to the manufacturer’s instructions.
Cells were depleted of p130Cas using siRNA corresponding to
nucleotides 2366–2384 (CCCACAAGCUGGUGUUACU dTdT)
of p130Cas [44] (Bioneer, Daejeon, Korea). Transfection of
control (nonsilencing fluorescein-labeled siRNA duplex; Bioneer)
or anti-p130Cas siRNA was performed in Opti-MEM I medium
(Invitrogen) using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA, USA), following the manufacturer’s instructions.
The transfection efficiency for the siRNAs, as determined from
images of fluorescein-labeled siRNA duplex, was consistently
.95%.
For cell adhesion assays, Cos7 and HeLa cells were serum
starved for 12 h, and A431 cells were serum starved 24 h, after
which they were detached and replated on culture dishes coated
with FN or PDL. The cells were then incubated with or without
100 ng/ml EGF in DMEM for the indicated times. EGF-induced
dynamin phosphorylation was performed as described previously
[29]. Briefly, cells transiently expressing GFP-dynamin I were
serum-starved for 12 h and then pretreated with 100 mMN a 3VO4
for 1 h followed by treatment with 100 ng/ml EGF for an
additional 30 min. For Texas Red-EGF and Texas Red-
transferrin uptake assays, the cells were serum starved as above,
after which they were chilled, washed with cold PBS and
incubated with 1 mg/ml Texas Red EGF or 25 mg/ml Texas
Red-transferrin for 1 h at 4uC. After washing away the unbound
ligand, the cells were rapidly warmed to 37uC for 15 min before
being fixed for immunofluorescence analysis.
Immunoprecipitation and Immunoblotting
Twenty-four hours after plasmid transfection or 60 h after
siRNA transfection, the cells were manipulated as described above
and then lysed in modified radioimmunoprecipitation assay buffer
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25%
sodium deoxycholate, 10 mM NaF, 1 mM PMSF, 1 mM
Na3VO4,1 0 mM leupeptin, 1.5 mM pepstatin, and 10 mg/ml
aprotinin). The lysates were cleared by centrifugation at
12,000 r.p.m for 10 min at 4uC, after which the appropriate
antibody was added to the supernatant and incubated for 4 h or
overnight at 4uC. The resultant immune complexes were
precipitated with protein A or G-Sepharose (GE Healthcare,
Piscataway, NJ, USA) for 3 h. The beads were then washed four
times with lysis buffer, suspended in SDS sample buffer, boiled for
10 min, resolved by SDS-PAGE and analyzed by immunoblotting
as described previously [45]. Tyrosine phosphorylation of EGFR
was analyzed by immunoprecipitation with anti-EGFR antibody,
followed by immunoblotting with anti-phospho-Tyr antibody.
Phosphorylation of GFP-anti-dynamin I and endogenous dynamin
II was detected by immunoprecipitation with anti-GFP or
dynamin II antibody, followed by immunoblotting with anti-
phospho-Tyr antibody. For analysis of the interaction of GFP-
dynamin with wild-type or mutant Myc-p130Cas, the lysates were
immunoprecipitated with anti-GFP followed by immunoblotting
with anti-Myc antibody. Interaction of GFP-dynamin with
endogenous p130Cas was analyzed by immunoprecipitation with
anti-p130Cas antibody followed by immunoblotting with anti-
GFP antibody. The resultant band intensities were measured using
ImageJ software (Ver. 1.43u, NIH, Bethesda, USA).
EGFR internalization assay
Cells transfected with siRNA or plasmid DNA were serum
starved for 12 h and treated with EGF-containing DMEM, as
indicated. They were then washed three times with cold PBS and
incubated with 0.5 mg/ml Sulfo-NHS-SS-Biotin (Thermo Scien-
tific, Waltham, MA, USA) in a borate buffer (10 mM boric acid,
150 mM NaCl, pH 8.0) for 1 h at 4uC with gentle shaking. The
reaction was quenched by adding ice-cold PBS containing 15 mM
glycine, after which the cells were washed with cold PBS, lysed and
precipitated using streptavidin-agarose resin (Thermo Scientific,
Waltham, MA, USA). The precipitates were then immunoblotted
with anti-EGFR antibody to detect cell surface EGFR. P130Cas
blots served as a negative control of membrane protein biotinyla-
tion. Aliquots of cell lysate were taken before the incubation with
streptavidin-agarose and analyzed by immunoblotting using the
indicated antibodies.
Immunofluorescence
To detect Texas Red-EGF, GFP-p130Cas, mRFP-dynamin or
Myc-p130Cas, the cells were treated as described in the figure
legends, fixed, permeabilized, blocked, incubated with the
appropriate primary antibody, and stained with Alexa Fluor-
conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA).
Immunohistochemical detection of Myc-p130Cas protein was
carried out using anti-Myc (clone 9E10) as the primary antibody,
and nuclei were labeled with Hoechst dye 33258 (Sigma, St Louis,
MO, USA). Images were obtained using an Olympus confocal
microscope FV1000 (Olympus, Tokyo, Japan) using FV10-
MSASW software or a Leica DMR upright fluorescence
microscope (Leica Microsystems, Wetzlar, Germany) driven by
MetaMorph imaging software (Ver. 6.3r6, Molecular Devices,
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measured using MetaMorph Offline image analysis software
(Ver. 7.6.0.0, Molecular Devices, Sunnyvale, CA).
GST pull-down assay
GST or GST-dynamin I PRD was expressed in Escherichia coli
and purified through adsorption onto glutathione-Sepharose 4B
beads (GE Healthcare, Piscataway, NJ, USA). Cell lysates were
prepared from Cos7 cells expressing Myc-Cas or Myc-only empty
vector using the modified radioimmunoprecipitation assay buffer
described above. Aliquots (2 mg) of cell lysate were incubated with
GST or GST-dynamin I PRD in binding buffer (50 mM HEPES,
pH 7.5, 150 mM NaCl, 0.1% Tween 20, 1 mM EDTA, 2.5 mM
EGTA, 10% glycerol, 1 mM dithiothreitol, 0.1 mM Na3VO4,
1 mM PMSF, and protease inhibitors), after which the beads were
extensively washed in the same buffer, and the adsorbed proteins
were separated by SDS-polyacrylamide gel electrophoresis and
visualized by immunoblotting with anti-Myc antibody.
Supporting Information
Figure S1 P130Cas modulates EGFR signaling differen-
tially depending on the cell type. (A) P130Cas depletion
reduces Neu-EGFR association in A431 cells. Depletion of
p130Cas from A431 cells alters EGF-induced EGFR signaling
(e.g., Neu-EGFR dimerization) [8,46]. A431 cells transfected with
non-targeting or p130Cas-specific siRNA were serum starved or
stimulated with EGF (100 ng/ml) for 60 min at 4uC and then
warmed for 10 min at 37uC. Cell lysates were used for
immunoprecipitation or immunoblot analysis with the indicated
antibodies. (B) FN-mediated cell adhesion increases phosphoryla-
tion of EGFR, Akt and Erk. Cos7 cells were incubated in
suspension (Sus) for 1 h and plated on FN for 30 min or 3 h. They
were then lysed, subjected to SDS-PAGE and immunoblotted
using the indicated antibodies. In all of our experiments, whole cell
lysate was also imunoblotted as indicated, and tubulin was used as
a loading control. (C) Overexpression of p130Cas enhances FN-
induced phosphorylation of EGFR and Akt, but not Erk. Cos7
cells were transfected with empty vector (GFP-EV) or GFP-
p130Cas (GFP-Cas) and treated as described in (B).
(TIF)
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